Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
161, P. 114465 - 114465
Published: March 3, 2023
Lipotoxicity
is
the
dysregulation
of
lipid
environment
and/or
intracellular
composition
that
leads
to
accumulation
harmful
lipids
and
ultimately
organelle
dysfunction,
abnormal
activation
signaling
pathways,
chronic
inflammation
cell
death.
It
plays
an
important
role
in
development
acute
kidney
injury
disease,
including
diabetic
nephropathy,
obesity-related
glomerulopathy,
age-related
polycystic
like.
However,
mechanisms
overload
remain
poorly
understood.
Herein,
we
discuss
two
pivotal
aspects
lipotoxic
injury.
First,
analyzed
mechanism
kidney.
Accumulating
data
indicate
different
diseases
are
inconsistent.
Second,
summarize
multiple
by
which
species
affect
behavior,
oxidative
stress,
endoplasmic
reticulum
mitochondrial
dysregulated
autophagy,
inflammation,
highlighting
central
stress.
Blocking
molecular
pathways
damage
may
be
potential
therapeutic
targets
for
antioxidant
drugs
play
a
treatment
disease
future.
Nature reviews. Immunology,
Journal Year:
2021,
Volume and Issue:
22(7), P. 429 - 443
Published: Nov. 5, 2021
Non-alcoholic
fatty
liver
disease
(NAFLD)
includes
a
range
of
hepatic
manifestations,
starting
with
steatosis
and
potentially
evolving
towards
non-alcoholic
steatohepatitis
(NASH),
cirrhosis
or
even
hepatocellular
carcinoma.
NAFLD
is
major
health
burden,
its
incidence
increasing
worldwide.
Although
it
primarily
disturbed
metabolism,
involves
several
immune
cell-mediated
inflammatory
processes,
particularly
when
reaching
the
stage
NASH,
at
which
point
inflammation
becomes
integral
to
progression
disease.
The
cell
landscape
diverse
steady
state
further
evolves
during
NASH
direct
consequences
for
severity.
In
this
Review,
we
discuss
current
concepts
related
role
cells
in
onset
NASH.
A
better
understanding
mechanisms
by
contribute
pathogenesis
should
aid
design
innovative
drugs
target
therapeutic
options
are
limited.
(NASH)
serious
chronic
disorder
prevalence
Metabolic
nature,
also
mobilizes
system.
Here,
Huby
Gautier
knowledge
regarding
how
subsets
affect
progression.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(9), P. 1653 - 1653
Published: Aug. 22, 2023
The
liver
is
an
organ
that
particularly
exposed
to
reactive
oxygen
species
(ROS),
which
not
only
arise
during
metabolic
functions
but
also
the
biotransformation
of
xenobiotics.
disruption
redox
balance
causes
oxidative
stress,
affects
function,
modulates
inflammatory
pathways
and
contributes
disease.
Thus,
stress
implicated
in
acute
injury
pathogenesis
prevalent
infectious
or
chronic
diseases
such
as
viral
hepatitis
B
C,
alcoholic
fatty
disease,
non-alcoholic
disease
(NAFLD)
steatohepatitis
(NASH).
Moreover,
plays
a
crucial
role
progression
fibrosis,
cirrhosis
hepatocellular
carcinoma
(HCC).
Herein,
we
provide
overview
on
effects
pathophysiology
mechanisms
by
promotes
Antioxidants,
Journal Year:
2021,
Volume and Issue:
11(1), P. 91 - 91
Published: Dec. 30, 2021
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
the
most
common
chronic
worldwide,
and
scientific
studies
consistently
report
that
NAFLD
development
can
be
accelerated
by
oxidative
stress.
Oxidative
stress
induce
progression
of
to
NASH
stimulating
Kupffer
cells,
hepatic
stellate
hepatocytes.
Therefore,
are
underway
identify
role
antioxidants
in
treatment
NAFLD.
In
this
review,
we
have
summarized
origins
reactive
oxygen
species
(ROS)
relationship
between
ROS
NAFLD,
discussed
use
as
therapeutic
agents
for
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(13), P. 6969 - 6969
Published: June 28, 2021
Chronic
diseases
represent
a
major
challenge
in
world
health.
Metabolic
syndrome
is
constellation
of
disturbances
affecting
several
organs,
and
it
has
been
proposed
to
be
liver-centered
condition.
Fructose
overconsumption
may
result
insulin
resistance,
oxidative
stress,
inflammation,
elevated
uric
acid
levels,
increased
blood
pressure,
triglyceride
concentrations
both
the
liver.
Non-alcoholic
fatty
liver
disease
(NAFLD)
term
widely
used
describe
excessive
infiltration
absence
alcohol,
autoimmune
disorders,
or
viral
hepatitis;
attributed
obesity,
high
sugar
fat
consumption,
sedentarism.
If
untreated,
NAFLD
can
progress
nonalcoholic
steatohepatitis
(NASH),
characterized
by
inflammation
mild
fibrosis
addition
and,
eventually,
advanced
scar
tissue
deposition,
cirrhosis,
finally
cancer,
which
constitutes
culmination
disease.
Notably,
fructose
recognized
as
mediator
NAFLD,
significant
correlation
between
intake
degree
found
preclinical
clinical
studies.
Moreover,
risk
factor
for
cancer
development.
Interestingly,
induces
number
proinflammatory,
fibrogenic,
oncogenic
signaling
pathways
that
explain
its
deleterious
effects
body,
especially
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(5), P. 2668 - 2668
Published: Feb. 28, 2022
Nonalcoholic
fatty
liver
disease
(NAFLD)
and
its
progressive
form
nonalcoholic
steatohepatitis
(NASH)
comprise
a
spectrum
of
chronic
diseases
in
the
global
population
that
can
lead
to
end-stage
hepatocellular
carcinoma
(HCC).
NAFLD
is
closely
linked
metabolic
syndrome,
comorbidities
such
as
type
2
diabetes,
obesity
insulin
resistance
aggravate
disease,
while
promotes
cardiovascular
risk
affected
patients.
The
pathomechanisms
are
multifaceted,
combining
hepatic
factors
including
lipotoxicity,
mechanisms
cell
death
inflammation
with
extrahepatic
disturbance
dysbiosis.
Nuclear
receptors
(NRs)
family
ligand-controlled
transcription
regulate
glucose,
fat
cholesterol
homeostasis
modulate
innate
immune
functions,
macrophages.
In
parallel
derangement
NAFLD,
altered
NR
signaling
frequently
observed
might
be
involved
pathogenesis.
Therapeutically,
clinical
data
indicate
single
drug
targets
thus
far
have
been
insufficient
for
reaching
patient-relevant
endpoints.
Therefore,
combinatorial
treatment
strategies
multiple
or
drugs
actions
could
possibly
bring
advantages,
by
providing
more
holistic
therapeutic
approach.
this
context,
peroxisome
proliferator-activated
(PPARs)
other
NRs
great
interest
they
wide-ranging
multi-organ
activities
associated
NASH
progression
regression.
review,
we
summarize
recent
advances
understanding
pathogenesis
focusing
on
death,
immunometabolism
role
NRs.
We
outline
novel
discuss
remaining
challenges.
Annals of Medicine,
Journal Year:
2022,
Volume and Issue:
54(1), P. 1548 - 1560
Published: May 28, 2022
Chronic
liver
disease
(CLD),
manifested
as
hepatic
injury,
is
a
major
cause
of
global
morbidity
and
mortality.
CLD
progresses
to
fibrosis,
cirrhosis,
and—ultimately—hepatocellular
carcinoma
(HCC)
if
left
untreated.
The
different
phenotypes
based
on
their
respective
clinical
features
causative
agents
include
alcoholic
(ALD),
non-alcoholic
fatty
(NAFLD),
metabolic-associated
(MAFLD),
drug-induced
injury
(DILI).
preferred
treatment
modality
for
includes
lifestyle
modification
diet,
along
with
limited
pharmacological
symptomatic
treatment.
Moreover,
oxidative
stress
(OS)
an
important
pathological
mechanism
underlying
all
phenotypes;
hence,
the
use
antioxidants
manage
justified.
Based
available
evidence,
silymarin
can
be
utilized
hepatoprotective
agent,
given
its
potent
antioxidant,
antifibrotic,
anti-inflammatory
properties.
role
in
suppressing
OS
has
been
well
established,
therefore
recommended
ALD
NAFLD
guidelines
approved
by
Russian
Medical
Scientific
Society
Therapists
Gastroenterology
Russia.
However,
discuss
positioning
original
protocols
agent
managing
concomitantly
other
therapies,
expert
panel
international
medical
professionals
was
convened
11
November
2020.
reviewed
approaches
prevention
OS,
existing
patient
management
CLD,
evidence
effectiveness
reducing
inflammation
presented
form
narrative
review.Key
messagesAn
ALD,
NAFLD,
MAFLD,
DILI
establish
consensus
recommendations
that
common
pathophysiological
these
conditions.The
also
discussed
therapies.The
140
mg
three
times
day
chronic
diseases
such
DILI.